Related Articles
Novel agent induction therapy alone or followed by autologous stem cell transplantation in younger patients with multiple myeloma: A single‑center retrospective study of 114 cases
Retrospective analysis of 264 multiple myeloma patients
Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation
Lenalidomide use in multiple myeloma (Review)
High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group